289 related articles for article (PubMed ID: 29309521)
1. Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study.
Baxter R; Bartlett J; Fireman B; Marks M; Hansen J; Lewis E; Aukes L; Chen Y; Klein NP; Saddier P
Am J Epidemiol; 2018 Jan; 187(1):161-169. PubMed ID: 29309521
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.
Klein NP; Bartlett J; Fireman B; Marks MA; Hansen J; Lewis E; Aukes L; Saddier P
Vaccine; 2019 Aug; 37(36):5422-5427. PubMed ID: 31301920
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records.
Klein NP; Bartlett J; Fireman B; Marks MA; Hansen J; Lewis E; Aukes L; Saddier P
BMJ; 2023 Nov; 383():e076321. PubMed ID: 37940142
[TBL] [Abstract][Full Text] [Related]
4. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.
Langan SM; Smeeth L; Margolis DJ; Thomas SL
PLoS Med; 2013; 10(4):e1001420. PubMed ID: 23585738
[TBL] [Abstract][Full Text] [Related]
5. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
Matthews I; Lu X; Dawson H; Bricout H; O'Hanlon H; Yu E; Nozad B
Vaccine; 2018 Nov; 36(46):7105-7111. PubMed ID: 30195489
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of shingles vaccine among Albertans aged 50 years or older: A retrospective cohort study.
McDonald BM; Dover DC; Simmonds KA; Bell CA; Svenson LW; Russell ML
Vaccine; 2017 Dec; 35(50):6984-6989. PubMed ID: 29128385
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia.
Lin J; Dobbins T; Wood JG; Bernardo C; Stocks NP; Liu B
Vaccine; 2021 Mar; 39(10):1493-1498. PubMed ID: 33581921
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.
Curran D; Van Oorschot D; Matthews S; Hain J; Salem AE; Schwarz M
Hum Vaccin Immunother; 2021 Dec; 17(12):5296-5303. PubMed ID: 34905463
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of herpes zoster vaccination in an older United Kingdom population.
Walker JL; Andrews NJ; Amirthalingam G; Forbes H; Langan SM; Thomas SL
Vaccine; 2018 Apr; 36(17):2371-2377. PubMed ID: 29555217
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
Zerbo O; Bartlett J; Fireman B; Lewis N; Goddard K; Dooling K; Duffy J; Glanz J; Naleway A; Donahue JG; Klein NP
Ann Intern Med; 2024 Feb; 177(2):189-195. PubMed ID: 38190712
[TBL] [Abstract][Full Text] [Related]
12. Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years.
Tseng HF; Harpaz R; Luo Y; Hales CM; Sy LS; Tartof SY; Bialek S; Hechter RC; Jacobsen SJ
J Infect Dis; 2016 Jun; 213(12):1872-5. PubMed ID: 26908728
[TBL] [Abstract][Full Text] [Related]
13. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
[TBL] [Abstract][Full Text] [Related]
14. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
Litt J; Booy R; Bourke D; Dwyer DE; Leeb A; McCloud P; Stein AN; Woodward M; Cunningham AL
Hum Vaccin Immunother; 2020 Dec; 16(12):3081-3089. PubMed ID: 32420793
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ
Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.
Tseng HF; Chi M; Smith N; Marcy SM; Sy LS; Jacobsen SJ
J Infect Dis; 2012 Jul; 206(2):190-6. PubMed ID: 22669900
[TBL] [Abstract][Full Text] [Related]
18. Safety of Zostavax™--a cohort study in a managed care organization.
Baxter R; Tran TN; Hansen J; Emery M; Fireman B; Bartlett J; Lewis N; Saddier P
Vaccine; 2012 Oct; 30(47):6636-41. PubMed ID: 22963800
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
20. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
